Adriana Di Marco
About Adriana Di Marco
Adriana Di Marco serves as the Director of CMC & Regulatory Affairs at Inversago Pharma, where she manages CMC aspects of drug submissions. With a background in regulatory compliance and quality assurance, she has held various positions in the pharmaceutical industry since 1999.
Current Role at Inversago Pharma
Adriana Di Marco serves as the Director of CMC & Regulatory Affairs at Inversago Pharma. In this role, she manages the Chemistry, Manufacturing, and Controls (CMC) aspects of all drug submissions. Her responsibilities include overseeing contract manufacturing activities, ensuring compliance with regulatory standards, and facilitating the development of pharmaceutical products. She has been with Inversago Pharma since 2020 and operates from their Montreal, Quebec location.
Previous Experience at ICON plc
Before joining Inversago Pharma, Adriana worked at ICON plc as a Senior CMC Manager from 2016 to 2020. During her four years in this position, she was based in Dundus, Ontario. Her role involved managing CMC processes and contributing to the regulatory submissions of various pharmaceutical products.
Background in Pharmaceutical Development
Adriana's career in pharmaceutical development includes a position as a CMC Specialist at Theratechnologies from 2008 to 2011. In this role, she focused on pharmaceutical development and contributed to the CMC aspects of drug submissions while working in Montreal, Quebec. Her experience in this area has been foundational to her current role.
Education and Qualifications
Adriana Di Marco holds a D.E.C in Chemical Technology from Dawson College, which she completed from 1985 to 1988. She furthered her education at Concordia University, where she earned a Bachelor of Science degree in Chemistry between 2005 and 2013. Her educational background provides her with a solid foundation in the scientific principles necessary for her work in CMC and regulatory affairs.
Regulatory Compliance Experience
Adriana has extensive experience in regulatory compliance, having worked at Galderma as a Regulatory Compliance Coordinator from 1999 to 2008. In this nine-year role, she was responsible for ensuring that products met regulatory standards. Additionally, she held positions at Valeant Pharmaceuticals as a Quality and Compliance Specialist and at Winpak as a QA Supervisor, further enhancing her expertise in quality assurance and regulatory affairs.